ANG Lifesciences India Limited (BOM:540694)
38.06
+2.31 (6.46%)
At close: Nov 6, 2026
ANG Lifesciences India Market Cap
ANG Lifesciences India has a market cap or net worth of 497 million as of November 6, 2026. It is the 44,526th most valuable company in the world and the 3,938th biggest in India. Its market cap has increased by 25.32% in one year.
Market Cap
497.00M
Enterprise Value
1.25B
Revenue
835.87M
Global Rank
Country Rank
#3,938 India
PE Ratio
n/a
ChartMarket Cap Chart
Since September 8, 2017, ANG Lifesciences India's market cap has decreased from 497.60M to 497.00M, a decrease of -0.12%. That is a compound annual growth rate of -0.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 497.00M | 28.80% |
| Dec 31, 2025 | 385.87M | -33.77% |
| Dec 31, 2024 | 582.66M | -35.72% |
| Dec 29, 2023 | 906.38M | -42.23% |
| Dec 30, 2022 | 1.57B | -67.78% |
| Dec 31, 2021 | 4.87B | 1,136.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Onyx Biotec | 652.76M |
| Rekvina Laboratories | 633.49M |
| Phaarmasia | 565.55M |
| Biofil Chemicals and Pharmaceuticals | 470.80M |
| Mangalam Drugs & Organics | 466.93M |
| Vista Pharmaceuticals | 381.01M |
| Rajnish Wellness | 365.53M |
| JFL Life Sciences | 354.70M |